Sulindac
Sulindac is a prodrug NSAID metabolized in vivo to an active form that induces apoptosis by inhibiting cGMP phosphodiesterase. It is used in cancer research, particularly in studies of colorectal and prostate cancer, for investigating apoptotic pathways in both cellular and animal models.
Product Specifications
CAS Number
38194-50-2
Product Name Alternative
Epithelial-mesenchymal transition (EMT), FDA, MK 231, MK231, MK-231, migration, immunomodulatory agent, Autophagy, Arthrocine, Clinoril, colorectal cancer (CRC), COX, Sulindac, Sulindac sulfoxide, pMMR, SIRT1
Field of Research
Cell Biology, Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.09% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.61 mM) ; Ethanol:9 mg/mL (25.25 mM) ; DMSO:250 mg/mL (701.44 mM)
Smiles
C (=C/1\C=2C (C (CC (O) =O) =C1C) =CC (F) =CC2) \C3=CC=C (S (C) =O) C=C3
Molecular Formula
C20H17FO3S
Molecular Weight
356.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6352581-01 0.2 mL
SUMO1, NT (SUMO1, SMT3C, SMT3H3, UBL1, Small ubiquitin-related modifier 1, GAP-modifying protein 1, SMT3 homolog 3, Sentrin, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein SMT3C, Ubiquitin-like protein UBL1) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6352581-02 5x 0.2 mL
SUMO1, NT (SUMO1, SMT3C, SMT3H3, UBL1, Small ubiquitin-related modifier 1, GAP-modifying protein 1, SMT3 homolog 3, Sentrin, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein SMT3C, Ubiquitin-like protein UBL1) (Azide free) (HRP)
Sign In for Pricing
View Details 
M2428-21-ML650 100 µL
Matrix Metalloproteinase 13 (MMP-13, Collagenase 3) (MaxLight 650) discontinued
Sign In for Pricing
View Details MBS9938905 Inquire
Chicken T Cell Receptor GammaDelta (TCRGD) ELISA Kit
Sign In for Pricing
View Details 